Can the conventional sextant prostate biopsy accurately predict unilateral prostate cancer in low-risk, localized, prostate cancer?

Published

Journal Article

We evaluate the reliability of routine sextant prostate biopsy to detect unilateral lesions. A total of 365 men with complete records including all clinical and pathologic variables who underwent a preoperative sextant biopsy and subsequent radical prostatectomy (RP) for clinically localized prostate cancer at our medical center between January 1996 and December 2006 were identified. When the sextant biopsy detects unilateral disease, according to RP results, the NPV is high (91%) with a low false negative rate (9%). However, the sextant biopsy has a PPV of 28% with a high false positive rate (72%). Therefore, a routine sextant prostate biopsy cannot provide reliable, accurate information about the unilaterality of tumor lesion(s).

Full Text

Duke Authors

Cited Authors

  • Mayes, JM; Mouraviev, V; Sun, L; Tsivian, M; Madden, JF; Polascik, TJ

Published Date

  • March 2011

Published In

Volume / Issue

  • 29 / 2

Start / End Page

  • 166 - 170

PubMed ID

  • 19451000

Pubmed Central ID

  • 19451000

Electronic International Standard Serial Number (EISSN)

  • 1873-2496

International Standard Serial Number (ISSN)

  • 1078-1439

Digital Object Identifier (DOI)

  • 10.1016/j.urolonc.2009.03.011

Language

  • eng